Evaluating Ruxolitinib With Pegylated Interferon Alfa-2A In Myelofibrosis

Evaluating Ruxolitinib With Pegylated Interferon Alfa-2a in Myelofibrosis

Targeted Oncology

RUXOPEG: a promising novel combination for MPN-associated myelofibrosis

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Kiladjian on Ruxolitinib Plus Interferon in MPNs

What can be learnt about using interferon in patients with myelofibrosis?

VJHemOnc – Video Journal of Hematology & HemOnc

Ongoing clinical trials of ruxolitinib-based combinations in myelofibrosis

VJHemOnc – Video Journal of Hematology & HemOnc

Thursday Webinars - Primary Myelofibrosis: diagnosis and treatment

ERN-EuroBloodNet's EDU

Safety and efficacy of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis

VJHemOnc – Video Journal of Hematology & HemOnc

Comparing Hydroxyurea and Pegylated Interferon-Alpha-2a in PV and ET

Targeted Oncology

Ruxolitinib combinations in patients with myelofibrosis

VJHemOnc – Video Journal of Hematology & HemOnc

Interferons and Myeloproliferative Neoplasms (MPNs)

Rare Disease Report

Diagnosis of Myelofibrosis

Pilot study of ropeginterferon in early myelofibrosis

VJHemOnc – Video Journal of Hematology & HemOnc

Phase I study of ruxolitinib plus abemaciclib for patients with myelofibrosis

VJHemOnc – Video Journal of Hematology & HemOnc

Ruxolitinib plus azacitidine for myelofibrosis

VJHemOnc – Video Journal of Hematology & HemOnc

Prognosis and Risk Stratification of Myelofibrosis

Evidence Supports Rechallenging of JAK Inhibitors in Myelofibrosis

Targeted Oncology

Myelofibrosis: Long-Term Survival Data and Ruxolitinib Use

Targeted Oncology

Dr. Harrison on 5-Year Follow-Up Data on Ruxolitinib in Patients With Myelofibrosis

The 5-year update on the COMFORT-II clinical trial of ruxolitinib

VJHemOnc – Video Journal of Hematology & HemOnc

Ropeginterferon alpha-2b as an effective treatment against PV

VJHemOnc – Video Journal of Hematology & HemOnc